The aim of the journal is to contribute to the literature by publishing clinical and experimental research articles, case reports, letters to the editor, and and editorial comments prepared in accordance with the ethical guidelines in all disciplines of health sciences. The target audience of the journal includes specialists and medical professionals working in all disciplines of health sciences.
Clinical and Experimental Health Sciences (Clin Exp Health Sci) is an international, scientific, open access periodical published in accordance with independent, unbiased, and double-blinded peer-review principles. The journal is the official publication of Marmara University Health Sciences Institute and it is published four times a year on March, June, September and December. The journal publishes content in English. The journal publishes clinical and experimental research articles, review articles, case reports, letters to the editor, and editorial comments prepared in accordance with ethical guidelines in all disciplines of health sciences.
Please find the two files below that you will use in the article submissiın process:
Clinical and Experimental Health Sciences (Clin Exp Health Sci) is an international, scientific, open access journal published in accordance with independent, unbiased and double-blinded peer-review principles. The journal is the official publication of Marmara University Institute of Health Sciences and it is published quarterly on March, June, September and December. The journal publishes clinical, experimental research and observational articles, review articles, case reports, letters to the editor and editorial comments prepared in accordance with ethical guidelines in all disciplines of health sciences.
The journal publishes articles written in English. Clinical and Experimental Health Sciences aims to reach an international audience and will accept submissions from authors worldwide. It gives high priority to original studies of interest to clinicians and scientists in applied and basic health sciences.
The editorial and publication processes of the journal are shaped in accordance with the guidelines of International Committee of Medical Journal Editors (ICMJE), the World Association of Medical Editors (WAME), the Council of Science Editors (CSE), the Committee on Publication Ethics (COPE), the European Association of Science Editors (EASE), and National Information Standards Organization (NISO). The journal conforms to the Principles of Transparency and Best Practice in Scholarly Publishing (doaj.org/bestpractice).
Originality, high scientific quality, and citation potential are the most important criteria for manuscript acceptance. Manuscripts submitted for evaluation should not have been previously published or submitted for publication elsewhere.
Manuscripts submitted to the journal will first go through a technical evaluation process where the editorial office will ensure that the manuscript has been prepared and submitted in accordance with the journal’s guidelines. Submissions that do not conform to the journal’s guidelines will be returned to the submitting author with technical correction requests.
Manuscripts passing the technical evaluation process will go through a double-blind peer-review process and will be reviewed by at least two external, independent peer reviewers who are experts in their fields. The Editor in Chief is the final authority in the decision-making process for all submissions.
Creative Commons License
Articles are freely available to read, download and share from the time of publication under the terms of Creative Commons Attribution-NonCommercial (CC BY-NC) 4.0 International License.
Research Articles: The main text of research articles should be structured in the sequence of Abstract, Keywords, Introduction, Methods, Results, Discussion, and Conclusion. ‘Aim of the study’ should be clearly indicated as the last paragraph of the Introduction section. Information on ‘ethics approval’ should be provided as the first paragraph of the Methods section. Please check Table 1 for the limitations for Research Articles.
Review Articles: Review articles prepared by authors who have extensive knowledge on a particular field and whose scientific background has been translated into a high volume of publications with a high citation potential are welcomed. Eminent authors may also be invited for their contribution with a review article by the editor of the journal. Reviews should describe, discuss, and evaluate the current level of knowledge of a topic in health sciences and should guide future studies. Review articles should be structured as follows: Abstract, Keywords, Introduction, aim of the review, body of the article structured by headings and subheadings and Conclusion. Please check Table 1 for the limitations for Review Articles.
Case Reports: There is limited space for case reports in the journal and reports on rare cases or conditions that constitute challenges in diagnosis and treatment, those offering new therapies or revealing knowledge not included in the literature, and interesting and educative case reports are accepted for publication. The text should be structured as follows: Abstract, Introduction, Case Presentation, Discussion, and Conclusion. Please check Table 1 for the limitations for Case Reports.
Letters to the Editor: This type of manuscript discusses important parts, overlooked aspects, or lacking parts of a previously published article. Articles on subjects within the scope of the journal that might attract the readers’ attention, particularly educative cases, may also be submitted in the form of a ‘Letter to the Editor’. Readers can also present their comments on a published article in the form of a ‘Letter to the Editor’. Abstract, Keywords, and Tables, Figures, Images, and other media should not be included. The text should be unstructured. The article that is being commented on must be properly cited within this manuscript.
Editorial Comments: Editorial comments aim to provide a brief critical commentary by reviewers with expertise or with high reputation in the topic of the research article published in the journal. Authors are selected and invited by the journal to provide such comments. Abstract, Keywords, and Tables, Figures, Images, and other media are not included.
The manuscripts should be prepared in accordance with ICMJE-Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (http://www.icmje.org/recommendations updated in December 2019).
Manuscript Formatting Requirements
|Programme ||Manuscripts must be in a Microsoft Word document.|
|Page size ||A4 size|
|Page margings ||Normal Margin (top, bottom, right and left margins: 2.5 cm)|
|Line spacing ||1,5|
|Font||Times New Roman|
|Alignment ||Left-aligned; without left indent|
|Statistical Analyses ||Statistical analyses must be conducted in accordance with SAMPL guidelines for statistical reporting [T. A. Lang and D.G. Altman. Basic Statistical Reporting for Articles Published in Biomedical Journals: The “Statistical Analyses and Methods in the Published Literature” or The SAMPL Guidelines” in: Smart P, Maisonneuve H, Polderman A (eds). Science Editors’ Handbook, European Association of Science Editors, 2013].|
In the text; If p values less than .001 it should be reported as p < .001. If p values less than .01 it should be reported as p < .01. If p values less than .05 it should be reported as p < .05.
In the tables; the actual p values should be expressed (p = .04)
|Decimal separator ||Use a point (.) NOT a comma (,) as decimal separator (eg. 34.2%).|
|Acronyms and Abbreviations||All acronyms and abbreviations used in the manuscript should be defined at first use, both in the abstract and in the main text. The abbreviation should be provided in parentheses following the first time use of the definition.|
When a drug, product, hardware, or software program is mentioned within the main text, product information, including the name of the product, the producer of the product, and city and the country of the company (including the state if in USA) should be provided in parentheses in the following format: “Discovery PET/CT scanner (General Electric, Milwaukee, WI, USA)”.
ABSTRACT (Objective; Methods; Results; Conclusion; Keywords)
|Abstract||Abstract should be submitted for research articles, review articles, and case reports. No abstract is needed for letters, editorials and notes. The abstract of Research Articles and Review Articles should be structured with subheadings (Objective, Methods, Results, and Conclusion). The abstract of short communications and case reports should not be structured. Please check Table 1 below for word count specifications.|
Each submission must be accompanied by a minimum of three to a maximum of five keywords for subject indexing at the end of the abstract. The keywords should be listed in full without abbreviations. The keywords should be selected from the National Library of Medicine, Medical Subject Headings database (https://www.nlm.nih.gov/mesh/MBrowser.html).
|Heading style and numbering||Section headings (eg. ABSTRACT, 1.INTRODUCTION, 2.METHODS, 3.RESULTS, 4.DISCUSSION, 5.CONCLUSION, REFERENCES) should be written in bold, capital letters. |
First-Order Subheading: The subheading should be written in bold letters and numbered; the first letter of each word of the subheading should be capitalized.
Second-Order Subheading: The subheading should be written in bold; the first letter of each word of the subheading should be capitalized.
Third-Order Subheading: The subheading should be written in bold, and numbered; the first letter of each word of the subheading should be capitalized.
Numbering should be continued in accordance with the number in the heading above.
|Language||Ensure that your work is written in correct English before submission. We recommend that authors have their manuscripts checked by an English language native speaker before final submission. They may also get support from commercial English editing and proofreading services.|
|Reporting Guidelines||Authors are required to prepare manuscripts in accordance with the CONSORT guidelines for randomized research studies, STROBE guidelines for observational original research studies, STARD guidelines for studies on diagnostic accuracy, PRISMA guidelines for systematic reviews and meta-analysis, ARRIVE guidelines for experimental animal studies, and TREND guidelines for non-randomized evaluations of behavioral and public health interventions. |
Consult the Equator Network for reporting guidelines (https://www.equator-network.org/) for a wide variety of study types.
|References||While citing publications, preference should be given to the latest, most up-to-date publications. Only the peer-reviewed articles (and proceeding abstracts) published in indexed journals can be cited as references. The cited references published in languages other than English can constitute at most 10% of all references. Theses cannot be cited as reference. References other than English should be written in the original language and the relevant language should be indicated in parentheses at the end (eg Turkish). |
Only if an ahead-of-print publication is cited, the DOI number should be provided. Authors are responsible for the accuracy of references. Journal titles should be abbreviated in accordance with the journal abbreviations in Index Medicus/ MEDLINE/PubMed. All authors of the cited articles should be listed at the references section.
Number the citations consecutively according to the first mention of each source in the text (using the same number for subsequent references to the same source). The reference number should be given in round brackets before the punctuation.
If more than one reference is cited for a statement, all of their numbers should be written in the round brackets separated with commas without any spaces. List the works cited, with corresponding numbers (without any brackets), on a new section after the text, titled REFERENCES. Please see the example below:
Operating room nurses have a significant role in ensuring and maintaining patient safety (1,2). When mentioned in the text, only surnames of authors are used (eg. Aricioglu (7) reported on the survey). For a 2- author reference, list both surnames (eg. Duru and Kadioglu (8) reported on the survey); for references with more than 2 authors or authors and a group, include the first author’s surname followed by “et al,” (eg. Duru et al (9) reported on the survey)
In reference lists, use the author’s surname followed by initials without periods. In listed references, the names of all authors should be given
The reference styles for different types of publications are presented in the following examples.
Journal Article: Altman DG, Gore SM, Gardner MJ, Pocock SJ. Statistical guidelines for contributors to medical journals. Br Med J. 1983;7(3):1489-1493. DOI: 10.1136/bmj.286.6376.1489
Books: Sweetman SC. Martindale the Complete Drug Reference. 34th ed. London: Pharmaceutical Press; 2005.
Book Section: Suh KN, Keystone JS. Malaria and babesiosis. Gorbach SL, Barlett JG, Blacklow NR, editors. Infectious Diseases. Philadelphia: Lippincott Williams; 2004.p.2290-2308.
Conference Proceedings: Bengisson S. Sothemin BG. Enforcement of data protection, privacy and security in medical informatics. In: Lun KC, Degoulet P, Piemme TE, Rienhoff O, editors. MEDINFO 92. Proceedings of the 7th World Congress on Medical Informatics; 1992 Sept 6-10; Geneva, Switzerland. Amsterdam: North-Holland; 1992. pp.1561-1565.
Scientific or Technical Report: Cusick M, Chew EY, Hoogwerf B, Agrón E, Wu L, Lindley A, et al. Early Treatment Diabetic Retinopathy Study Research Group. Risk factors for renal replacement therapy in the Early Treatment Diabetic Retinopathy Study (ETDRS), Early Treatment Diabetic Retinopathy Study Kidney Int: 2004. Report No: 26.
Epub Ahead of Print Articles: Cai L, Yeh BM, Westphalen AC, Roberts JP, Wang ZJ. Adult living donor liver imaging. Diagn Interv Radiol. 2016 Feb 24. doi: 10.5152/dir.2016.15323. [Epub ahead of print]. DOI:10.5152/dir.2016.15323
Websites: World Health Organization (or Author). Critical preparedness, readiness and response actions for COVID-19. Published [22 March 2020]. Updated [27 May 2021]. Accessed [06 March 2022]. https://www.who.int/publications/i/item/critical-preparedness-readiness-and-response-actions-for-covid-19
|Tables||Tables must be in editable Microsoft Word documents by using “insert table” function. |
Tables should be included in the main document, presented after the reference list, and they should be numbered consecutively in the order they are referred within the main text. A descriptive title must be placed above the tables. Table titles should be written in italic and in sentence case (ie. capitalize the first letter of a sentence and leave all other letters as lowercase) [eg. Table 1. Adjusted all-cause and cause-specific mortality in 2001].
Abbreviations used in the tables should be defined below the tables by footnotes (even if they are defined within the main text). Tables should be created using the “insert table” command of the word processing software and they should be arranged clearly to provide easy reading. Data presented in the tables should not be a repetition of the data presented within the main text but should be supporting the main text.
|Figures and Figure Legends ||Figures, graphics, and photographs should be submitted as separate files (in TIFF or JPEG format) through the submission system. The files should not be embedded in a Word document or the main document. When there are figure subunits, the subunits should not be merged to form a single image. Each subunit should be submitted separately through the submission system. Images should be labeled (a, b, c, etc.) to indicate figure subunits. Thick and thin arrows, arrowheads, stars, asterisks, and similar marks can be used on the images to support figure legends. Any information within the images that may indicate an individual or institution should be blinded. The minimum resolution of each submitted figure should be 600 DPI. To prevent delays in the evaluation process, all submitted figures should be clear in resolution and large in size (minimum dimensions: 100×100 mm). Figure legends should be listed at the end of the main document. |
All figures should be referred to within the main text, and they should be numbered consecutively in the order they are referred to within the main text. Figure legends should be written in italic and in sentence case (ie. capitalize the first letter of a sentence and leave all other letters as lowercase) [eg. Figure 1. Death rates by cause in 2001].
|Cover Letter||A separate “Cover Letter” file should be submitted|
|Title Page||A separate “Title Page” file should be submitted. Please follow this link for a template|
|Copyright Agreement and Acknowledgement of Authorship Form|
All those designated as authors should meet all four criteria for authorship, and all who meet the four criteria should be identified as authors. Those who do not meet all four criteria should be acknowledged in the title page of the manuscript.
Conflict of Interest Disclosure
|Similarity Report||Authors are requested to check their submissions for the presence and rate of similarity by a similarity detection software (eg. iThenticate by CrossCheck, intihal.net by TUBITAK). Only submissions with <20% similarity can proceed to the technical control and peer review stages. In the event of alleged or suspected research misconduct, e.g., plagiarism, citation manipulation, and data falsification/fabrication, the Editorial Board will follow and act in accordance with COPE guidelines.|
|Ethics Approval Document||Ethical Principles|
An approval of research protocols by the Ethics Committee in accordance with international agreements (World Medical Association Declaration of Helsinki “Ethical Principles for Medical Research Involving Human Subjects,” amended in October 2013, www.wma.net) is required for experimental, clinical, drug studies and case reports. If required, ethics committee reports or an equivalent official document is to be provided by the authors. For manuscripts concerning experimental research on humans, a statement that shows the written informed consent from participants was obtained following a detailed explanation of the experimental procedures should be included in the text. Likewise, for studies carried out on animals an ethical committee report should be stated. Information on consents, the name of the ethics committee, and the ethics committee approval number should also be stated in the Methods section of the manuscript. It is the authors’ responsibility to carefully protect the participants’ anonymity. For photographs that may reveal the identity of the participants, signed releases of the participants or of their legal representative should be enclosed.
All authors are required to follow the privacy and informed consent from patients and study participants. Please confirm that any patient, service user, or participant (or that person’s parent or legal guardian) in any research, has given written consent on the inclusion to the study. The authors are responsible for the scientific content of the material to be published, and should complete and save the Patient Consent Form and send to the journal if requested.
|Blinded Main Text|
|Type of Manuscript||Word Limit (Main Text Only)||Abstract Word Limit||Reference Limit||Table Limit||Figure Limit|
|Letter to the Editor||500||N/A||5||No table||No media|
All the manuscripts should be submitted through the https://dergipark.org.tr/tr/pub/clinexphealthsci system. Manuscripts submitted via any other way will not be evaluated.
When submitting a revised version of a paper, corresponding author must submit a detailed “Response to the reviewers” that states point by point how each issue raised by the reviewers has been covered and where it can be found (each reviewer’s comment, followed by the author’s reply and page and line numbers where the changes have been made) as well as an annotated copy of the main document. Disagreements with any recommendations should be explained in details. Correspondent author should prepare a document in which her/his respond to each recommendations of reviewers and upload it as a separate file named “Response to reviewers”. Author's name should not appear on revised manuscripts. The revised manuscript must be uploaded with the same ID (Do not upload as a new submission).
If the title of the article have been revised, these changes should be made both in the title page and Dergipark system (in Overview). If the abstract and bibliography of the article have been revised, these changes should be made in the Dergipark system (in Overview).
Revised manuscripts must be submitted within 15 days from the date of the decision letter. If the revised version of the manuscript is not submitted within the allocated time, the revision option may be canceled. If the submitting author(s) believe that additional time is required, they should request this extension before the initial 15-day period is over.
Accepted manuscripts are copy-edited for grammar, punctuation, and format. Once the publication process of a manuscript is completed, it is published online on the journal’s webpage as an ahead-of-print publication before it is included in its scheduled issue. A PDF proof of the accepted manuscript is sent to the corresponding author and their publication approval is requested within 2 days of their receipt of the proof.
Note: The abbreviated name of the journal is Clin Exp Health Sci.
Before publication, proofs of edited copy in .pdf format are submitted electronically to the corresponding author who is responsible for checking the accuracy of the material.
Withdrawing a manuscript that has been submitted to our journal for publication is never advisable and should only be considered when necessary. The manuscript withdrawal request must be made using the Manuscript Withdrawal Form.
Ethical Responsibilities of the Publisher;
The publisher of the Journal of Clinical and Experimental Health Sciences is Marmara University Publisher, and is affiliated to the Marmara University Library and Documentation Department, which is a non-profit public institution. Clinical and Experimental Health Sciences journal is the scientific journal of Marmara University Institute of Health Sciences, covering all studies in the field of health sciences since 2011 and continues its publishing life successfully without compromising ethical principles. The journal is indexed in ESCI list.
Ethical Responsibilities of the Authors;
TR Index Journal Evaluation criteria were updated and the items related to the ethics committee approval, which required for scientific research were detailed. Therefore, the following criteria regarding ethics committee approvals will be sought / applied in the articles submitted to the Clinical and Experimental Health Sciences journal, which is mandatory for publications whose process started in 2020.
1. Researches requiring Ethics Committee approval are as follows;
2. Retrospective approval of the Ethics Committee is not required for the following studies: Using research data before 2020, produced from master's/doctoral studies (should be stated in the article), articles submitted for publication before 2020, accepted but not yet published.
3. It should be stated in the content of the article whether the ethics committee approval and/or legal/special ermission is required in the submitted articles. According to the above information, if these permissions are required, it should be clearly stated in the article from which institution, when and with which decision number the permission was obtained.
4. If the research requires the use of human and animal subjects, it must be declared that the research was performed in accordance with international declaration, guidelines, etc.
5. Researchers who are not members of the university can apply to the local/regional Ethics Committees.
Ethical Responsibilities of the Reviewers;
The Responsibilities of Editors, Associate Editor and Field Editors;
Failure to Comply with Ethical Principles;
In cases where there is a situation or behavior that does not comply with the ethical principles regarding the articles published in the Journal of Clinical and Experimental Health Sciences, editorial process, reviewers or authors, this should be sent to firstname.lastname@example.org.
No fee is charged during the article acceptance and publication process of the journal